Rainbow Children's Medicare Limited
NSE: RAINBOWMarket Closed • NSE
Day range
52 week range
Rainbow Children's Medicare Limited closed at INR1250.20 (+1.58%) on volume 0.51x its 20-day average, trading 22.35% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved -19.2% QoQ
2026-07-21
DIVIDEND Announced
Dividend - Rs 3.50 Per Share
2025-06-27
DIVIDEND Announced
Dividend - Rs 3 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Strong Capital Efficiency: ROCE stands at 17.4%
High Cash Flow Conversion: CFO/PAT averaged 1.54x over last 3 years
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Medical Care Facilities.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Ownership distribution
Category trends
Hover over a period for exact holdings
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 21 Jul 2026 | Dividend | ₹3.50 / share | — | 21 Jul 2026 |
| 28 Jun 2025 | Dividend | ₹3.00 / share | — | 27 Jun 2025 |
| 23 Jul 2024 | Dividend | ₹3.00 / share | — | 23 Jul 2024 |
| 22 Jun 2023 | Dividend | ₹3.00 / share | — | 22 Jun 2023 |
| 08 Sept 2022 | Dividend | ₹2.00 / share | — | 07 Sept 2022 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries LimitedSUNPHARMA Open analysis | ₹4.22L | 34.92 | 0.91% | ₹15,300.00 | ₹2,901.00 | +10.46% | +26.52% |
 Divi's Laboratories LimitedDIVISLAB Open analysis | ₹2.48L | 84.75 | 0.32% | ₹3,080.00 | ₹902.00 | +27.80% | +65.50% |
 Torrent Pharmaceuticals LimitedTORNTPHARM Open analysis | ₹1.77L | 74.39 | 0.82% | ₹4,128.00 | ₹389.00 | +41.90% | -21.89% |
 LENSKART SOLUTIONS LTDLENSKART Open analysis | ₹1.17L | 183.15 | 0.00% | ₹2,714.00 | ₹228.00 | +43.29% | +273.77% |
 Apollo Hospitals Enterprise LimitedAPOLLOHOSP Open analysis | ₹1.15L | 55.26 | 0.26% | ₹7,044.00 | ₹610.00 | +20.58% | +38.32% |
 Zydus Lifesciences LimitedZYDUSLIFE Open analysis | ₹1.11L | 24.91 | 0.09% | ₹8,017.00 | ₹990.00 | +21.95% | -34.91% |
 Laurus Labs LimitedLAURUSLABS Open analysis | ₹1.10L | 100.67 | 0.12% | ₹2,026.31 | ₹367.60 | +29.10% | +125.49% |
 Cipla LimitedCIPLA Open analysis | ₹1.05L | 31.20 | 0.99% | ₹7,119.00 | ₹786.00 | +2.33% | -39.16% |
Rainbow Children's Medicare Limited operates a multi-specialty pediatric, obstetrics, and gynecology hospital chain in India. The company offers a wide range of services such as newborn and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care, obstetrics, and gynecology. [1] It is country’s largest pediatric hospital chain with 16 hospitals spread across 6 cities.[2]
IndiaHealthcare
Is Rainbow Children's Medicare Limited Shariah compliant?
Rainbow Children's Medicare Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (7.02%) complies with AAOIFI threshold (≤ 33%).
What is Rainbow Children's Medicare Limited's current valuation relative to peers?
Rainbow Children's Medicare Limited trades at a P/E of 44.5x compared to the sector median of 37.6x, and a Price-to-Book of 7.7x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.54x. Interest coverage is 5.1x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at 5.8% while net profit growth averaged 5.1%.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-09. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.